Skip to main content
. 2019 Dec;5(6):a004648. doi: 10.1101/mcs.a004648

Table 2.

Detection of tumor-specific next-generation sequencing (NGS) mutations by ddPCR in samples obtained within the first month following surgery

Sample origin Sample type NGS PTEN NGS TP53 ddPCR PTEN ddPCR TP53
Allele frequency Major allele (FW, RV) Minor allele (FW, RV) Allele frequency Major allele (FW, RV) Minor allele (FW, RV) Allele frequency Allele frequency
Right fallopian tube tDNA 76.3 173 276 585 959 75.0 498 597 1605 1908 78.0 75.0
Colonic tumor tDNA 4.8 979 2052 54 103 4.2 3924 6031 181 274 3.3 5.1
Sigmoid tumor tDNA 35.4 598 1010 350 549 35.8 1629 1885 917 1087 24.3 36.5
Pelvic wash cfDNA 23.2 1184 1790 393 525 28.2 3553 4137 1443 1631 25.5 29.0
Plasma day of surgery cfDNA 0.6 1201 2295 11 11 0.8 3963 4114 30 35 1.9 1.4
Plasma 8 d postsurgery cfDNA neg. n/a n/a n/a n/a 0.8 6744 7918 63 71 0.2 0.4

(NGS) Next-generation sequencing, (ddPCR) droplet digital polymerase chain reaction, (FW) forward, (RV) reverse, (tDNA) transfer DNA, (cfDNA) circulating free DNA.